CYTENA - Disruptive Technologies for In Vitro Personalized Predictive Diagnostics

Watch Cytenas Webinar from December 1st, 2021 to learn about technologies that speed up timelines and reduce costs in cancer research, drug discovery and personalized medicine applications.

Aquarray participates with Dr. Anna Popova who presents the Droplet Microarray (DMA) that is used to automate analysis und its applications for High-Throughput Screening af live cells in 2D and 3D.